UBXN8 and acute myeloid leukemia: Together, these results indicated that restoration of UBXN8 expression significantly contributes to the inhibition of malignant cell proliferation and the promotion of malignant cell differentiation, which makes this a promising therapeutic approach for treating t(8;21) AML.